Intensifying Insulin Therapy from Basal Insulin to Biphasic Insulin Aspart (BIAsp 30) Improves Glucose Control and Treatment Satisfaction in Patients with Type 2 Diabetes: South Korea Subgroup of IMPROVE™ Study

被引：0
|
作者：
Kim, Chong Hwa
Jeong, Su Jin
Mok, Ji Oh
Ryu, Ohk Hyun
Lee, Kiyoung
Jeong, In Kyung
Lee, Byung Wan
Kim, Hyun Jin
Lee, Sora
Kim, Sun Woo
机构：
来源：
DIABETES | 2010年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A566 / A566
页数：1
相关论文
共 50 条
  • [31] Switching patients from human premix insulin to biphasic insulin aspart 30 leads to improved glycaemic control: a subgroup analysis of Korean patients with Type 2 diabetes in the PRESENT study
    Oh, Seung Joon
    Kim, Jong Hwa
    Park, Suk O.
    Son, Suk Man
    Song, Sun Kyung
    Lee, So Ra
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 : S65 - S65
  • [32] Transferring type 2 diabetes patients with uncontrolled glycaemia from biphasic human insulin to biphasic insulin aspart 30: experiences from the PRESENT study
    Shestakova, M.
    Sharma, S. K.
    Almustafa, M.
    Min, K. W.
    Ayad, N.
    Azar, S. T.
    Danciulescu, R.
    Khutsoane, D.
    Guler, S.
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (12) : 3209 - 3214
  • [33] Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: Chinese PRESENT study
    Gao, Y.
    Guo, X. H.
    Vaz, J. A.
    DIABETES OBESITY & METABOLISM, 2009, 11 (01): : 33 - 40
  • [34] Improved postprandial glycemic control with biphasic insulin aspart relative to biphasic insulin lispro and biphasic human insulin in patients with type 2 diabetes
    Hermansen, K
    Colombo, M
    Storgaard, H
    Ostergaard, A
    Kolendorf, K
    Madsbad, S
    DIABETES CARE, 2002, 25 (05) : 883 - 888
  • [35] Effect of biphasic insulin aspart on glucose and lipid control in patients with Type 2 diabetes mellitus
    Lalic, N. M.
    Antic, Micic S.
    Bajovic, L.
    Pantelinac, P.
    Jotic, A.
    Kendereski, A.
    Dimic, D.
    Djukic, A.
    Mitrovic, M.
    Vujasin, M.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (17) : 2895 - 2901
  • [36] Biphasic insulin aspart 30: Better glycemic control than with premixed human insulin 30 in obese patients with Type 2 diabetes
    M. Velojic-Golubovic
    D. Mikic
    M. Pesic
    D. Dimic
    S. Radenkovic
    S. Antic
    Journal of Endocrinological Investigation, 2009, 32 : 23 - 27
  • [37] Comparison of biphasic insulin aspart (BIAsp30) and insulin glargine (IGlarg) during isoglycaemic clamp studies in persons with type 2 diabetes
    Luzio, SD
    Peter, R
    Dunseath, GJ
    Pauvaday, V
    Owens, DR
    DIABETES, 2004, 53 : A136 - A136
  • [38] Insulin Degludec/Insulin Aspart (IDegAsp) Provides Superior FPG Control and Reduced Hypoglycaemia vs. Biphasic Insulin Aspart 30 (BIAsp 30) in Insulin-Naive Adults with Type 2 Diabetes in a Randomized Phase 3 Trial
    Franek, Edward
    Haluzik, Martin
    Canecki-Varzic, Silvija
    Sargin, Mehmet
    Macura, Stanislava
    Zacho, Jeppe
    Christiansen, Jens Sandahl
    DIABETES, 2014, 63 : A225 - A225
  • [39] Biphasic insulin aspart 30: Better glycemic control than with premixed human insulin 30 in obese patients with Type 2 diabetes
    Velojic-Golubovic, M.
    Mikic, D.
    Pesic, M.
    Dimic, D.
    Radenkovic, S.
    Antic, S.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2009, 32 (01) : 23 - 27
  • [40] Biphasic Insulin Aspart 30 as Initiation Therapy in Chinese Insulin-Naive Subjects with Inadequately Controlled Type 2 Diabetes-IMPROVE™ China Subgroup Data
    Gao, Yan
    Yang, Wenying
    Liu, Guoliang
    Chen, Lulu
    Fu, Zuzhi
    Zou, Dajin
    Feng, Ping
    Zhao, Zhigang
    DIABETES, 2009, 58 : A516 - A517
12345